Remove Marketing Remove Pharma Companies Remove Pharma Production Remove Regulation
article thumbnail

COVID-19 and the digital pharma marketing revolution

pharmaphorum

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications.

Marketing 100
article thumbnail

Is License Compulsory For Starting Pharmaceutical Business In India?

Fossil Remedies

When you launch a PCD pharma company , you have to do several preparations. In a pharma business, you have a distribution network like a pharma manufacturing company, pharma marketing company, C&F agents, wholesalers/distributors/stockiest, retailers, and pharmacies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Another reason change is needed at FDA? Fair balance

World of DTC Marketing

Pharma TV ads drive people online to search for more information. Safety pages on Pharma product websites continue to have high utility. Only requirement in TV ads should be for “boxed” products. If the FDA understood consumer behavior like marketers instead of scientists, they would understand how DTC works.

Doctors 165
article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Compared with other emerging pharmaceutical markets (such as India and China, covered in previous Emerging Market Outsourcing Reports), Russian facilities lack many US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals, meaning Russian manufacturing is more focused on the domestic market.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

article thumbnail

Brexit fallout continues with batch testing concerns

Pharmaceutical Technology

In principle, the deal could create new opportunities for British pharma companies – not least the chance to work under a more supportive regulatory framework. Among the negative effects that have been reported are supply chain disruptions, skills shortages, issues around market authorisation, and added costs for pharma CMOs.

Medicine 290
article thumbnail

How pharmaceutical firms are making their supply chains more efficient

Pharmaceutical Technology

Dealing with different regulations and stakeholders across diverse regions means there are many points in the journey where something can go wrong. Given these potential vulnerabilities, visibility is essential for organisations seeking to accurately track their products and ensure they are safe to use.